Thomas Schinecker became CEO of Roche in March.
Keystone
Swiss pharmaceuticals group Roche is not ruling out further acquisitions.
This content was published on
2 minutes
Keystone-SDA/ds
But a major takeover must make “scientific and financial sense”, says the company’s CEO, Thomas Schinecker.
Interviewed on Sunday in the NZZ am Sonntag, he says he does not want to speculate on figures.
Schinecker has been at the helm of the Basel-based group since March. The worst approach, he says, would be “for the new guy to come in and say this is how we do it”. His task is to create the framework conditions so that changes can be implemented as quickly as possible, he adds.
Highly innovative projects
He says he has noticed a potential for improvement in the quality of research projects. When it comes to highly innovative molecules, the pharmaceutical group is at the forefront, he explains. But “it’s true that we also have a number of projects where we’re only in the middle of the pack”.
Future investments will therefore be geared more towards highly innovative projects, he continues, stressing that the most promising projects must also progress more rapidly.
Roche’s three research centers in Basel, California and Japan will remain independent, according to the CEO, who does not envisage any reorganisation. “Such a measure would lead to insecurity among employees and paralyze the organization for years to come,” he says.
More
More
The end of affordable medicine
This content was published on
Pharma companies are close to a cure for cancer, but will the hefty price tags make treatments unaffordable for most of the world?
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles. You can find them here.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
Should raw milk sales be banned or should consumers decide?
Swiss food regulations do not allow raw milk to be sold for direct consumption. However, a loophole allows 400 raw milk vending machines to do just that.
Most Swiss don’t fall asleep without their mobile phone
This content was published on
The mobile phone has replaced the book on most Swiss bedside tables. According to a survey conducted by Ikea, nearly 60% of them won't go to sleep without their mobile. This rate soars to 79% among 18-39 year-olds.
Switzerland deports two Afghan criminals to Afghanistan
This content was published on
Switzerland deported two Afghans with a criminal conviction to Kabul. It marks the first deportation of this kind since 2019. The Taliban took over in 2021.
Swiss safe after shelling of UN headquarters in Lebanon
This content was published on
Israeli forces on Thursday shelled the UNIFIL headquarters in southern Lebanon, injuring two UN soldiers. Swiss military observers
Only 11% of companies in line with Paris Agreement
This content was published on
Only 11 percent of listed companies worldwide are currently operating in line with the 1.5 degree target of the Paris Climate Agreement. This is the conclusion of an analysis by the US financial services provider MSCI.
This content was published on
A committee in Switzerland's senate is pushing for a ban on Hezbollah, a Lebanon-based militia and sworn enemy of Israel.
Personal care products affect indoor air quality, warns Swiss study
This content was published on
A Swiss study claims that typical personal care products can have a ‘significant impact’ on air quality when used in enclosed spaces.
Roche to focus on R&D, no job cuts in 2023, says new CEO
This content was published on
The Swiss pharma giant intends to invest more in research and development this year, according to Roche’s new CEO Thomas Schinecker.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.